CHRO Chromocell Earnings per share growth rate in current year
The 12-month earnings per share growth rates on the GURU.Markets chart demonstrate current yields, where the value 0.00 captures the metric level. Chromocell Therapeutics (CHRO) builds intellectual capital through the study of ion channels for licensing purposes. The development of neuromedicine relies on partnerships with scientific centers to create analgesics. Currently, R&D resources are focused on trials of selective pain blockers.
Analytical breakdowns and data insights for company Chromocell Therapeutics (CHRO)
- price and consensus price forecast:
- market capitalization data:
- balance sheet equity data:
- debt burden and liquidity indicators:
Debt to Equity Chromocell Therapeutics|CHRO - Long-Term Debt to Equity|Short-Term Debt to Equity chromocell.com|CHRO - Company Total Debt|Debt to Net Assets Ratio Chromocell|CHRO - Company Long-Term Liabilities|Amount of Current Liabilities Chromocell Therapeutics|Intermediate Coverage Ratio chromocell.com
- net income and valuation ratios data:
CHRO - Net Profit|Expected Net Profit Chromocell Therapeutics|CHRO - Price to Earnings Ratio|Future Price to Earnings Multiple Chromocell|CHRO - PEG Multiple|EV/EBITDA Multiple Chromocell|CHRO - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Chromocell Therapeutics|CHRO - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months chromocell.com|CHRO - Net earnings per share growth this year|Earnings growth forecast for next year Chromocell Therapeutics
- sales volume and revenue information:
Summary company analysis:Chromocell Therapeutics Corp (CHRO)
This indicator measures the annual rate of change in net income per share, allowing for an assessment of return on equity dynamics. Analyzing the EPS YoY trajectory helps determine the resilience of cash flows to market volatility. The ratio of the current figure to the previous period reflects the effectiveness of Chromocell (CHRO) in monetizing its intellectual property in ion channels through licensing agreements with pharma behemoths.
Key competitors
Net earnings per share growth this year Biogen Inc|Earnings per share growth in current year Neurocrine Biosciences Inc|Earnings per share growth rate in current year Regencell Corp RGC|Earnings growth in current year AXSM|Net earnings per share growth this year acadia-pharm.com ACAD|Earnings growth in current year XENE (Xenon)|Viking Therapeutics Inc (VKTX) - Earnings per share growth rate in current year|SUPN - Earnings per share growth in current year|CPRX: Earnings per share growth in current year|Denali Therapeutics (DNLI) - Earnings per share growth in current year|HRMY (harmonybiosciences.com) - Earnings per share growth in current year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Net earnings per share growth this year TRVI (Trevi Pharma)|Net earnings per one share growth for the current year PRAX|Earnings growth in current year AVXL (Anavex Life Sciences)|Earnings per share increase in current year CBLL|Prothena - Earnings growth in current year|Earnings per share growth rate in current year Alector, Inc.|Annexon Inc. (ANNX) - Earnings per share growth in current year|Omeros - Earnings per share increase in current year|NGNE (Neurogene Inc.) - Earnings growth in current year|Earnings growth in current year acimmune.com|Earnings per share growth in current year Voyager Therapeutics, Inc. (VYGR)|NMRA: Earnings per share trend in current year|Earnings growth in current year SCLX (Scilex Holding Co.)|Tevogen Bio Inc. (TVGN) - Earnings per share growth rate in current year|ACOG: Net earnings per share growth this year|CGTX - Earnings growth in current year|IKT (Inhibikase Therapeutics, Inc.) - Net earnings per share growth this year|SAVA: Net earnings per one share growth for the current year|ASRT (Assertio Holdings) - Earnings growth in current year|Coya (COYA) - Expected net earnings per share growth this year|Earnings growth in current year VTGN|Net earnings per share growth this year ovidrx.com OVID|Earnings per share growth in current year Acumen Pharmaceuticals, Inc. ABOS|Expected net earnings per share growth this year CervoMed, Inc. (CRVO)|Alterity Therapeutics Ltd - Earnings growth in current year|Clene Inc. (CLNN) - Net earnings per share growth this year|PEPG: Earnings growth in current year|Jupiter Neurosciences, Inc. - Earnings per share increase in current year|Earnings per share growth in current year Relmada Therapeutics, Inc.|ANVS: Earnings per share increase in current year|Earnings per share growth in current year Grace Therapeutics, Inc. (GRCE)|AIFF - Earnings per share growth rate in current year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|Reviva Pharmaceuticals Holdings, Inc. - Earnings growth in current year|Earnings per share growth rate in current year MetaVia Inc|NRXS (NeurAxis, Inc) - Net earnings per share growth this year|Helius Medical Technologies (HSDT) - Earnings growth in current year|Earnings per share growth in current year Passage Bio Inc.|NEUP: Earnings per share increase in current year|Earnings per share growth in current year Minerva Neurosciences, Inc. (NERV)|ATHA - Earnings per share growth rate in current year|Earnings growth in current year ADXN (Addex Therapeutics, Ltd.)|ALZN - Net earnings per share growth this year|Cyclerion - Earnings growth in current year|Earnings per share increase in current year PTIX (Protagenic Therapeutics)|pasitheaclinics.com (KTTA) - Earnings per share growth in current year|Cortigent - Earnings per share increase in current year|Earnings per share growth in current year Avenue Therapeutics, Inc|Earnings per share growth rate in current year BrainStorm Cell Therapeutics Inc. BCLI|Earnings per share growth in current year Cara Therapeutics, Inc. (CARA)|Net earnings per share growth this year eliemtx.com ELYM|Earnings per share growth in current year Intra-Cellular Therapies, Inc. ITCI|Longboard Pharmaceuticals Inc (LBPH) - Earnings per share growth rate in current year|Marinus - Earnings growth in current year|NKGen Biotech Corp (NKGN) - Net earnings per share growth this year|NRBO: Earnings growth in current year|Earnings per share growth rate in current year sagerx.com (SAGE)|Earnings per share growth in current year Synaptogenix|Earnings per share growth in current year TRVN|Earnings per share growth in current year Vigil Neuroscience (VIGL)|Earnings per share growth in current year WENA (anewmeds.com)|Cerevel Therapeutics - Net earnings per share growth this year
